卡塔尔基金会的Sidra Medicine正式落成,开启医疗保健新时代

2018-11-14 美通社 美通社

卡塔尔基金会主席谢赫-莫扎-宾特-纳赛尔殿下(Sheikha Moza bint Nasser)今天正式为Sidra Medicine揭牌,这是在卡塔尔新建的世界领先妇女儿童医院。该医院的盛大开业体现了该国更加专注和致力于为国民以及当地和国际患者提供转型的医疗保健服务。卡塔尔基金会主席谢赫-莫扎-宾特-纳赛尔殿下今天正式为Sidra Medicine揭牌,这是在卡塔尔新建的世界领先妇女儿童医院。该

卡塔尔基金会主席谢赫-莫扎-宾特-纳赛尔殿下(Sheikha Moza bint Nasser)今天正式为Sidra Medicine揭牌,这是在卡塔尔新建的世界领先妇女儿童医院。该医院的盛大开业体现了该国更加专注和致力于为国民以及当地和国际患者提供转型的医疗保健服务。

generated by system

卡塔尔基金会主席谢赫-莫扎-宾特-纳赛尔殿下今天正式为Sidra Medicine揭牌,这是在卡塔尔新建的世界领先妇女儿童医院。该医院的盛大开业体现了该国更加专注和致力于为国民以及当地和国际患者提供转型的医疗保健服务。

作为同类中最具雄心的绿地医院之一,Sidra Medicine代表着谢赫-莫扎-宾特-纳赛尔殿下的愿景,即开发该地区领先的学术医疗中心,并为卡塔尔及其他国家的人们提供符合全球最高标准的医疗保健服务。该高科技医院坐落在由世界领先建筑师西萨-佩里(Cesar Pelli)设计的醒目建筑中。该医院凭借其为妇女、儿童和年轻人提供医疗服务的远大目标,吸引了超过95个国家的4000多名训练有素的临床医师和后勤员工。

Sidra Medicine首席执行官Peter Morris在医院开业典礼上表示:“Sidra Medicine的愿景是成为学习、发现和卓越护理领域的指引者。在谢赫-莫扎-宾特-纳赛尔殿下的领导下,我们已在很短的时间内取得了巨大的进展,为我们的未来成功奠定了坚实的基础。在Sidra Medicine,我们拥有具有全球竞争力的临床医师和科学人员,作为一家出色的新医院,我们还拥有一流的设备和技术。”

Sidra Medicine的专家使用术中磁共振(MRI)和机器人辅助外科系统等领先技术,专注于治疗各种高度复杂且具有挑战性的病症。一些儿童专科服务包括心脏科神经内科泌尿科以及整形外科和颅面复原。

该医院将通过提供卡塔尔和中东和北非地区很多国家之前没有的医疗服务,满足这些市场对儿科和妇产科专家不断增长的需求。该医院还是领先生物医学研究领域的开创者,通过与Qatar Biobank卡塔尔基因组计划(QGP)合作,有可能为具体疾病的高度个性化和针对性治疗提供支持。作为卡塔尔基金会的成员,QGP是一个基于人口的远大项目,旨在生成有关卡塔尔人口的基因组排序和分子数据,并将这些数据与国家电子病历系统对接,为个性化给药提供支持。

Sidra Medicine在其很多其他优先研究项目中,专注于开发详细的流行病数据,以了解卡塔尔儿童糖尿病的生物化学和分子诊断。该医院目前正在构建准确的数据库,以揭示整体儿科群体的糖尿病发病原因,目标是为Sidra Medicine的每个患儿定制治疗方案。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1858915, encodeId=85df185891528, content=<a href='/topic/show?id=e0a9593596' target=_blank style='color:#2F92EE;'>#DIC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5935, encryptionId=e0a9593596, topicName=DIC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7770, createdName=jeanqiuqiu, createdTime=Sun Jun 16 14:18:00 CST 2019, time=2019-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1773745, encodeId=58351e737450d, content=<a href='/topic/show?id=5f014e1852' target=_blank style='color:#2F92EE;'>#CIN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4718, encryptionId=5f014e1852, topicName=CIN)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9a038523631, createdName=kalseyzl, createdTime=Mon Jan 14 13:18:00 CST 2019, time=2019-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1525891, encodeId=fa3d1525891c3, content=<a href='/topic/show?id=22a03480efa' target=_blank style='color:#2F92EE;'>#医疗保健#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34807, encryptionId=22a03480efa, topicName=医疗保健)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8eb511671747, createdName=drj2007, createdTime=Fri Nov 16 12:18:00 CST 2018, time=2018-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1577636, encodeId=b92815e7636ce, content=<a href='/topic/show?id=cda91148004' target=_blank style='color:#2F92EE;'>#Medicine#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11480, encryptionId=cda91148004, topicName=Medicine)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54cd16396700, createdName=ms1692212821629096, createdTime=Fri Nov 16 12:18:00 CST 2018, time=2018-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1582685, encodeId=fab31582685ed, content=<a href='/topic/show?id=36455839121' target=_blank style='color:#2F92EE;'>#新时代#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58391, encryptionId=36455839121, topicName=新时代)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Fri Nov 16 12:18:00 CST 2018, time=2018-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1603949, encodeId=5d041603949d3, content=<a href='/topic/show?id=f06536499c1' target=_blank style='color:#2F92EE;'>#卡塔尔#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36499, encryptionId=f06536499c1, topicName=卡塔尔)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d37d19121627, createdName=旅苦化文_214, createdTime=Fri Nov 16 12:18:00 CST 2018, time=2018-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1609311, encodeId=0b81160931159, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Fri Nov 16 12:18:00 CST 2018, time=2018-11-16, status=1, ipAttribution=)]
    2019-06-16 jeanqiuqiu
  2. [GetPortalCommentsPageByObjectIdResponse(id=1858915, encodeId=85df185891528, content=<a href='/topic/show?id=e0a9593596' target=_blank style='color:#2F92EE;'>#DIC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5935, encryptionId=e0a9593596, topicName=DIC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7770, createdName=jeanqiuqiu, createdTime=Sun Jun 16 14:18:00 CST 2019, time=2019-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1773745, encodeId=58351e737450d, content=<a href='/topic/show?id=5f014e1852' target=_blank style='color:#2F92EE;'>#CIN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4718, encryptionId=5f014e1852, topicName=CIN)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9a038523631, createdName=kalseyzl, createdTime=Mon Jan 14 13:18:00 CST 2019, time=2019-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1525891, encodeId=fa3d1525891c3, content=<a href='/topic/show?id=22a03480efa' target=_blank style='color:#2F92EE;'>#医疗保健#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34807, encryptionId=22a03480efa, topicName=医疗保健)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8eb511671747, createdName=drj2007, createdTime=Fri Nov 16 12:18:00 CST 2018, time=2018-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1577636, encodeId=b92815e7636ce, content=<a href='/topic/show?id=cda91148004' target=_blank style='color:#2F92EE;'>#Medicine#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11480, encryptionId=cda91148004, topicName=Medicine)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54cd16396700, createdName=ms1692212821629096, createdTime=Fri Nov 16 12:18:00 CST 2018, time=2018-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1582685, encodeId=fab31582685ed, content=<a href='/topic/show?id=36455839121' target=_blank style='color:#2F92EE;'>#新时代#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58391, encryptionId=36455839121, topicName=新时代)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Fri Nov 16 12:18:00 CST 2018, time=2018-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1603949, encodeId=5d041603949d3, content=<a href='/topic/show?id=f06536499c1' target=_blank style='color:#2F92EE;'>#卡塔尔#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36499, encryptionId=f06536499c1, topicName=卡塔尔)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d37d19121627, createdName=旅苦化文_214, createdTime=Fri Nov 16 12:18:00 CST 2018, time=2018-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1609311, encodeId=0b81160931159, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Fri Nov 16 12:18:00 CST 2018, time=2018-11-16, status=1, ipAttribution=)]
    2019-01-14 kalseyzl
  3. [GetPortalCommentsPageByObjectIdResponse(id=1858915, encodeId=85df185891528, content=<a href='/topic/show?id=e0a9593596' target=_blank style='color:#2F92EE;'>#DIC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5935, encryptionId=e0a9593596, topicName=DIC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7770, createdName=jeanqiuqiu, createdTime=Sun Jun 16 14:18:00 CST 2019, time=2019-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1773745, encodeId=58351e737450d, content=<a href='/topic/show?id=5f014e1852' target=_blank style='color:#2F92EE;'>#CIN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4718, encryptionId=5f014e1852, topicName=CIN)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9a038523631, createdName=kalseyzl, createdTime=Mon Jan 14 13:18:00 CST 2019, time=2019-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1525891, encodeId=fa3d1525891c3, content=<a href='/topic/show?id=22a03480efa' target=_blank style='color:#2F92EE;'>#医疗保健#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34807, encryptionId=22a03480efa, topicName=医疗保健)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8eb511671747, createdName=drj2007, createdTime=Fri Nov 16 12:18:00 CST 2018, time=2018-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1577636, encodeId=b92815e7636ce, content=<a href='/topic/show?id=cda91148004' target=_blank style='color:#2F92EE;'>#Medicine#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11480, encryptionId=cda91148004, topicName=Medicine)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54cd16396700, createdName=ms1692212821629096, createdTime=Fri Nov 16 12:18:00 CST 2018, time=2018-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1582685, encodeId=fab31582685ed, content=<a href='/topic/show?id=36455839121' target=_blank style='color:#2F92EE;'>#新时代#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58391, encryptionId=36455839121, topicName=新时代)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Fri Nov 16 12:18:00 CST 2018, time=2018-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1603949, encodeId=5d041603949d3, content=<a href='/topic/show?id=f06536499c1' target=_blank style='color:#2F92EE;'>#卡塔尔#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36499, encryptionId=f06536499c1, topicName=卡塔尔)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d37d19121627, createdName=旅苦化文_214, createdTime=Fri Nov 16 12:18:00 CST 2018, time=2018-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1609311, encodeId=0b81160931159, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Fri Nov 16 12:18:00 CST 2018, time=2018-11-16, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1858915, encodeId=85df185891528, content=<a href='/topic/show?id=e0a9593596' target=_blank style='color:#2F92EE;'>#DIC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5935, encryptionId=e0a9593596, topicName=DIC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7770, createdName=jeanqiuqiu, createdTime=Sun Jun 16 14:18:00 CST 2019, time=2019-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1773745, encodeId=58351e737450d, content=<a href='/topic/show?id=5f014e1852' target=_blank style='color:#2F92EE;'>#CIN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4718, encryptionId=5f014e1852, topicName=CIN)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9a038523631, createdName=kalseyzl, createdTime=Mon Jan 14 13:18:00 CST 2019, time=2019-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1525891, encodeId=fa3d1525891c3, content=<a href='/topic/show?id=22a03480efa' target=_blank style='color:#2F92EE;'>#医疗保健#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34807, encryptionId=22a03480efa, topicName=医疗保健)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8eb511671747, createdName=drj2007, createdTime=Fri Nov 16 12:18:00 CST 2018, time=2018-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1577636, encodeId=b92815e7636ce, content=<a href='/topic/show?id=cda91148004' target=_blank style='color:#2F92EE;'>#Medicine#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11480, encryptionId=cda91148004, topicName=Medicine)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54cd16396700, createdName=ms1692212821629096, createdTime=Fri Nov 16 12:18:00 CST 2018, time=2018-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1582685, encodeId=fab31582685ed, content=<a href='/topic/show?id=36455839121' target=_blank style='color:#2F92EE;'>#新时代#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58391, encryptionId=36455839121, topicName=新时代)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Fri Nov 16 12:18:00 CST 2018, time=2018-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1603949, encodeId=5d041603949d3, content=<a href='/topic/show?id=f06536499c1' target=_blank style='color:#2F92EE;'>#卡塔尔#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36499, encryptionId=f06536499c1, topicName=卡塔尔)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d37d19121627, createdName=旅苦化文_214, createdTime=Fri Nov 16 12:18:00 CST 2018, time=2018-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1609311, encodeId=0b81160931159, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Fri Nov 16 12:18:00 CST 2018, time=2018-11-16, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1858915, encodeId=85df185891528, content=<a href='/topic/show?id=e0a9593596' target=_blank style='color:#2F92EE;'>#DIC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5935, encryptionId=e0a9593596, topicName=DIC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7770, createdName=jeanqiuqiu, createdTime=Sun Jun 16 14:18:00 CST 2019, time=2019-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1773745, encodeId=58351e737450d, content=<a href='/topic/show?id=5f014e1852' target=_blank style='color:#2F92EE;'>#CIN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4718, encryptionId=5f014e1852, topicName=CIN)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9a038523631, createdName=kalseyzl, createdTime=Mon Jan 14 13:18:00 CST 2019, time=2019-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1525891, encodeId=fa3d1525891c3, content=<a href='/topic/show?id=22a03480efa' target=_blank style='color:#2F92EE;'>#医疗保健#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34807, encryptionId=22a03480efa, topicName=医疗保健)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8eb511671747, createdName=drj2007, createdTime=Fri Nov 16 12:18:00 CST 2018, time=2018-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1577636, encodeId=b92815e7636ce, content=<a href='/topic/show?id=cda91148004' target=_blank style='color:#2F92EE;'>#Medicine#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11480, encryptionId=cda91148004, topicName=Medicine)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54cd16396700, createdName=ms1692212821629096, createdTime=Fri Nov 16 12:18:00 CST 2018, time=2018-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1582685, encodeId=fab31582685ed, content=<a href='/topic/show?id=36455839121' target=_blank style='color:#2F92EE;'>#新时代#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58391, encryptionId=36455839121, topicName=新时代)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Fri Nov 16 12:18:00 CST 2018, time=2018-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1603949, encodeId=5d041603949d3, content=<a href='/topic/show?id=f06536499c1' target=_blank style='color:#2F92EE;'>#卡塔尔#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36499, encryptionId=f06536499c1, topicName=卡塔尔)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d37d19121627, createdName=旅苦化文_214, createdTime=Fri Nov 16 12:18:00 CST 2018, time=2018-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1609311, encodeId=0b81160931159, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Fri Nov 16 12:18:00 CST 2018, time=2018-11-16, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1858915, encodeId=85df185891528, content=<a href='/topic/show?id=e0a9593596' target=_blank style='color:#2F92EE;'>#DIC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5935, encryptionId=e0a9593596, topicName=DIC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7770, createdName=jeanqiuqiu, createdTime=Sun Jun 16 14:18:00 CST 2019, time=2019-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1773745, encodeId=58351e737450d, content=<a href='/topic/show?id=5f014e1852' target=_blank style='color:#2F92EE;'>#CIN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4718, encryptionId=5f014e1852, topicName=CIN)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9a038523631, createdName=kalseyzl, createdTime=Mon Jan 14 13:18:00 CST 2019, time=2019-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1525891, encodeId=fa3d1525891c3, content=<a href='/topic/show?id=22a03480efa' target=_blank style='color:#2F92EE;'>#医疗保健#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34807, encryptionId=22a03480efa, topicName=医疗保健)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8eb511671747, createdName=drj2007, createdTime=Fri Nov 16 12:18:00 CST 2018, time=2018-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1577636, encodeId=b92815e7636ce, content=<a href='/topic/show?id=cda91148004' target=_blank style='color:#2F92EE;'>#Medicine#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11480, encryptionId=cda91148004, topicName=Medicine)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54cd16396700, createdName=ms1692212821629096, createdTime=Fri Nov 16 12:18:00 CST 2018, time=2018-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1582685, encodeId=fab31582685ed, content=<a href='/topic/show?id=36455839121' target=_blank style='color:#2F92EE;'>#新时代#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58391, encryptionId=36455839121, topicName=新时代)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Fri Nov 16 12:18:00 CST 2018, time=2018-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1603949, encodeId=5d041603949d3, content=<a href='/topic/show?id=f06536499c1' target=_blank style='color:#2F92EE;'>#卡塔尔#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36499, encryptionId=f06536499c1, topicName=卡塔尔)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d37d19121627, createdName=旅苦化文_214, createdTime=Fri Nov 16 12:18:00 CST 2018, time=2018-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1609311, encodeId=0b81160931159, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Fri Nov 16 12:18:00 CST 2018, time=2018-11-16, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1858915, encodeId=85df185891528, content=<a href='/topic/show?id=e0a9593596' target=_blank style='color:#2F92EE;'>#DIC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5935, encryptionId=e0a9593596, topicName=DIC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7770, createdName=jeanqiuqiu, createdTime=Sun Jun 16 14:18:00 CST 2019, time=2019-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1773745, encodeId=58351e737450d, content=<a href='/topic/show?id=5f014e1852' target=_blank style='color:#2F92EE;'>#CIN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4718, encryptionId=5f014e1852, topicName=CIN)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9a038523631, createdName=kalseyzl, createdTime=Mon Jan 14 13:18:00 CST 2019, time=2019-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1525891, encodeId=fa3d1525891c3, content=<a href='/topic/show?id=22a03480efa' target=_blank style='color:#2F92EE;'>#医疗保健#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34807, encryptionId=22a03480efa, topicName=医疗保健)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8eb511671747, createdName=drj2007, createdTime=Fri Nov 16 12:18:00 CST 2018, time=2018-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1577636, encodeId=b92815e7636ce, content=<a href='/topic/show?id=cda91148004' target=_blank style='color:#2F92EE;'>#Medicine#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11480, encryptionId=cda91148004, topicName=Medicine)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54cd16396700, createdName=ms1692212821629096, createdTime=Fri Nov 16 12:18:00 CST 2018, time=2018-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1582685, encodeId=fab31582685ed, content=<a href='/topic/show?id=36455839121' target=_blank style='color:#2F92EE;'>#新时代#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58391, encryptionId=36455839121, topicName=新时代)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Fri Nov 16 12:18:00 CST 2018, time=2018-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1603949, encodeId=5d041603949d3, content=<a href='/topic/show?id=f06536499c1' target=_blank style='color:#2F92EE;'>#卡塔尔#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36499, encryptionId=f06536499c1, topicName=卡塔尔)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d37d19121627, createdName=旅苦化文_214, createdTime=Fri Nov 16 12:18:00 CST 2018, time=2018-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1609311, encodeId=0b81160931159, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Fri Nov 16 12:18:00 CST 2018, time=2018-11-16, status=1, ipAttribution=)]
    2018-11-16 hb2008ye